Alfasigma S.p.a.

This study is testing a daily pill called filgotinib to see if it can help control ulcerative colitis in children and teenagers aged 8 to 18. About 80 young people with moderate to severe symptoms will take the medication for up to 22 weeks to see if it reduces bowel inflammation…

This study is testing a medication called filgotinib in children and teenagers with juvenile idiopathic arthritis (JIA). The main goals are to see how the drug behaves in the body, if it's safe, and if kids can tolerate it. It's an early-phase study for children aged 8 to 18 whos…